Dysport has annualized worldwide sales of roughly $500M. Sales reported by Ipsen were €$164M ($194M) in 1H17 and were €77M ($91M) in 3Q17 (a seasonally slow period); Ipsen’s reported figures include amounts sold by Galderma in North America, but not amounts sold by Galderma in the rest of world:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.